In this special bonus episode, familiar guest Dr Steph Daly returns for a cameo conversation with Hilton. Drawing on her involvement in an ongoing clinical trial, Steph shares emerging insights into the role of blood-based biomarkers in assessing people presenting with cognitive symptoms in general practice, and what this evolving evidence could mean for future clinical pathways.
Show Notes
- Alzheimer’s Association® Clinical Practice Guideline: Integrating Blood-Based Biomarkers in Alzheimer’s Disease Specialized Care https://pro.alz.org/files/download/E224A154-A199-4DE6-92DA-0B2F87727B70.pdf
- Roche Elecsys Phospho-Tau (181P) Product Information - https://elabdoc-prod.roche.com/eLD/api/downloads/e21936a3-0b6c-f011-3091-005056a772fd?countryIsoCode=au
- JAMA Network - Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care - Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care | Neurology | JAMA | JAMA Network
- ADNeT - Blood Based Biomarker Study - enquiry information for GPs in Melbourne, Adelaide and Newcastle - Blood-Based Biomarkers for Alzheimer’s Disease in Primary Care: A Before and After Study - Australian Dementia Network
- Dementia Training Australia – General Practitioners Hub - https://dta.com.au/general-practitioners/
- RACGP Quick Log for GP CPD - https://mycpd.racgp.org.au/log



